NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8871761
SERIAL NO

13627091

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is directed to novel compounds of formula I

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
OGEDA SARUE ADRIENNE BOLLAND 47 CHARLEROI 6041

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Dutheuil, Guillaume Vedrin, BE 30 141
Fraser, Graeme Lovat Bousval, BE 5 22
Hoveyda, Hamid R Brussels, BE 42 506
Roy, Marie-Odile Paris, FR 11 80

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 28, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00